Successful use of bivalirudin for cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia.
Department of Anesthesiology, New England Medical Center Hospital, Boston, Massachusetts 02111, USA. ggordon@lifespan.org
George
G
Gordon
Hassan
H
Rastegar
Roman
R
Schumann
Judith
J
Deiss-Shrem
William
W
Denman
D018686:Anesthetics, Intravenous; D000925:Anticoagulants / Q000627:therapeutic use*; D001022:Aortic Valve Insufficiency / Q000601:surgery; D002315:Cardiopulmonary Bypass; D019918:Heart Valve Prosthesis Implantation; D006493:Heparin / Q000009:adverse effects*; D006629:Hirudins / Q000031:analogs & derivatives*; D006801:Humans; D007262:Infusions, Intravenous; D008103:Liver Cirrhosis / Q000601:surgery; D008297:Male; D008875:Middle Aged; D010446:Peptide Fragments / Q000627:therapeutic use*; D015742:Propofol; D011994:Recombinant Proteins / Q000627:therapeutic use*; D051437:Renal Insufficiency / Q000601:surgery; D017409:Sufentanil; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000628:therapy*; D014914:Whole Blood Coagulation Time
D018686:Anesthetics, Intravenous; D000925:Anticoagulants; D006629:Hirudins; D010446:Peptide Fragments; D011994:Recombinant Proteins; D006493:Heparin; D017409:Sufentanil; C074619:bivalirudin; D015742:Propofol